Page 893 - The Veterinary Care of the Horse
P. 893

•    The  drug  cisplatin  is  sometimes  injected  into  small  nodular  and  fibroblastic  sarcoids.

             Repeat injections are often required.
  VetBooks.ir  •  The human BCG vaccine may be injected into nodular or fibroblastic sarcoids close to

             the  eye.  This  is  repeated  1  week  later,  then  2  weeks  later  and  again  after  a  further  3
             weeks. The injection interval is extended by a week each time until the lesion regresses.

             The aim is to stimulate the immune system of the horse to reject the tumour tissue. A
             drawback of this treatment is the risk of the horse developing anaphylactic shock as a
             result of the foreign proteins. Thus the patient should be carefully monitored for 12–14

             hours following each treatment. To reduce the risk of anaphylactic shock, the horse is
             usually premedicated with a combination of flunixin, a cortiosteroid and an antihistamine

             before the tumour is injected. Some swelling occurs following the injection. At the time
             of writing the BCG vaccine is not available in the UK.



        SURGICAL EXCISION

        Surgical  removal  of  small,  discrete  tumours  with  a  wide  margin  of  healthy  skin  can  be
        successful. However, there is quite a high rate of recurrence at a variable time (months to

        years) afterwards. Wound breakdown sometimes occurs following surgical excision.
             Incomplete removal of a tumour may cause it to grow rapidly and become even more of a

        problem. Laser surgery has a higher success rate but is not suitable for sarcoids of all types
        and locations and is not universally available.



        APPLICATION OF AN ELASTIC BAND OR LIGATURE

        Single  tumours  that  have  a  narrow  base  may  be ‘tied  off’ using  a tight,  nylon  ligature  or
        special elastic band. The blood supply is cut off and after some initial swelling at the site, the
        tumour usually drops off 2–3 weeks later. Recurrence is common.



        CRYOSURGERY

        This  involves  removing  the  bulk  of  the  tumour(s)  surgically  and  freezing  any  remaining
        tissue. It is then allowed to thaw and the procedure is repeated twice more. This is carried out

        under sedation with local anaesthetic or general anaesthesia. It can be successful but again
        there is a high recurrence rate afterwards. Cryosurgery is not suitable for tumours close to the

        eye or over joints owing to the risk of damage to these structures.


        VACCINATION

        Vaccination against sarcoids is not currently available but may be in the future.
   888   889   890   891   892   893   894   895   896   897   898